Catalyst

Slingshot members are tracking this event:

Tradipitant Phase 2 trial by Vanda Pharmaceuticals (VNDA) in treating Gastroparesis should see results in fourth quarter of 2017

Source Link:
https://seekingalpha.com/article/4053316-vanda-pharmaceuticals-vnda-presents-cowen-company-37th-annual-health-care-conference

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VNDA Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 17, 2017
Occurred Source:
http://www.itchwroclaw.pl/
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Tradipitant, Gastroparesis, Phase 2 Clinical Trial Data
About Us
Media Center
Connect with Us
© 2026 Slingshot Insights. All rights reserved.